Related Experiment Video

Updated: May 14, 2026

Measurement of Carotenoids in Perifovea using the Macular Pigment Reflectometer
09:35

Measurement of Carotenoids in Perifovea using the Macular Pigment Reflectometer

Published on: January 29, 2020

Do statins have a role in the prevention of age-related macular degeneration?

Sean W Tsao1, Donald S Fong

  • 1Department of Ophthalmology, Southern California Permanente Medical Group, Baldwin Park, CA 91101, USA. Sean.Wade.Tsao@kp.org

Drugs & Aging
|February 21, 2013
PubMed

Insights

Hydroxymethylglutaryl-CoA reductase inhibitors (statins) may not prevent age-related macular degeneration (AMD). Current evidence is insufficient to confirm statin use benefits for AMD prevention, despite conflicting observational study results.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Pharmacology

Background:

  • Age-related macular degeneration (AMD) is a primary cause of vision loss globally, with limited preventive options.
  • Shared risk factors and pathophysiology between cardiovascular disease and AMD suggest potential benefits of statins.
  • Statins, or hydroxymethylglutaryl-CoA reductase inhibitors, are widely used for cardiovascular health.

Purpose of the Study:

  • To evaluate the hypothesis that statin use may prevent the onset or progression of age-related macular degeneration (AMD).
  • To synthesize existing evidence from observational studies and identify gaps in randomized controlled trials regarding statins and AMD.

Main Methods:

  • Review of observational studies investigating the association between statin use and AMD risk.
  • Analysis of existing literature, noting the absence of completed randomized controlled trials.
  • Consideration of specific statin use characteristics and their potential impact on AMD risk.

Main Results:

  • Observational studies have yielded conflicting conclusions regarding statin efficacy in preventing AMD.
  • Some studies suggest a potential protective effect against drusen, a precursor to AMD.
  • Evidence indicates a lack of preventive effect for exudative AMD, while evidence for dry AMD remains insufficient.

Conclusions:

  • There is currently insufficient scientific evidence to definitively conclude whether statin use is beneficial in preventing age-related macular degeneration (AMD).
  • Further high-quality randomized controlled trials are needed to clarify the role of statins in AMD prevention and management.

More Related Videos

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration09:24

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration

Published on: March 10, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...